The emerging therapy of tirzepatide peptide represents a significant advance in the care of type 2 diabetes. Unlike existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide230751.blogzet.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-57129201